Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01960413 |
|---|---|
| Brief Title: | Phase 2 Study of Montelukast for the Treatment of Sickle Cell Anemia |
| First Submitted : | October 8, 2013 |
| First Submitted that Met QC Criteria : | October 8, 2013 |
| First Posted : | October 10, 2013 (Estimate) |
| Results First Submitted : | March 7, 2019 |
| Results First Submitted that Met QC Criteria : | March 7, 2019 |
| Results First Posted : | March 26, 2019 |
| Last Update Submitted that Met QC Criteria : | March 7, 2019 |
| Last Update Posted : | March 26, 2019 |